Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index; 21 of the 46 sources its claims cite were checked for support.
Abstract
Recent work suggested that the activity of extracellular signal-regulated kinase 1/2 (ERK1/2) is increased in the retinal pigment epithelium (RPE) of age-related macular degeneration (ARMD) patients and therefore could be an attractive therapeutic target. Notably, ERK1/2 pathway inhibitors are used in cancer therapy, with severe and noncharacterized ocular side effects. To decipher the role of ERK1/2 in RPE cells, we conditionally disrupted the Erk1 and Erk2 genes in mouse RPE. The loss of ERK1/2 activity resulted in a significant decrease in the level of RPE65 expression, a decrease in ocular retinoid levels concomitant with low visual function, and a rapid disorganization of RPE cells, ultimately leading to retinal degeneration. Our results identify the ERK1/2 pathway as a direct regulator of the visual cycle and a critical component of the viability of RPE and photoreceptor cells. Moreover, our results caution about the need for a very fine adjustment of kinase inhibition in cancer or ARMD treatment in order to avoid ocular side effects.
Overview
CoChat Summary
TL;DR
RPE-specific deletion of ERK1/2 in adult mice causes early RPE65 downregulation via reduced C-FOS/FRA-1 binding to an AP-1 site, retinoid depletion, and progressive RPE/retinal degeneration. These findings argue that ERK1/2 inhibition proposed for ARMD treatment must be reevaluated because ERK1/2 is needed for RPE maintenance and visual function.
Key findings
- RPE-DKO mice showed fundus depigmentation, significant reduction of all retinal and choroidal layers by OCT at 4 months, and impaired ERG at 2 months, with absence or severe reduction of a and b waves under scotopic 50 mcd s/m² and absence of stimulation under photopic 10 mcd s/m².
- Ocular retinoids were depleted: dark-adapted retinas had decreases of more than half in 11-*cis*-retinal and all-*trans*-retinal, choroidal retinyl esters were significantly reduced, and light-exposed all-*trans*-retinol and retinyl esters were significantly lower than controls.
- Retinal degeneration was severe: ONL and INL thicknesses were reduced by 50% after 2 months and up to 70% after 4 months; GNAT2 was reduced by more than 60% at 4 months; qPCR cone markers decreased 60–80% at 4 months; at 1 year the ONL disappeared, the INL was drastically thinned, and no cone or rod staining remained.
- Mechanistically, RPE65 mRNA and protein were decreased by about 50% at 1 month and already at 2 weeks; LRAT was mislocalized; the RPE65 promoter AP-1 site was required for U0126 sensitivity; and C-FOS and FRA-1 binding/protein levels were reduced in RPE-DKO RPE and after ERK1/2 inhibition.
Methods
- Mice: *Erk1*−/−; *Erk2* f/f mice were crossed with VMD2-rtTA/TRE-Cre mice; two intraperitoneal injections of 10 μg doxycycline 1 week apart at 2 months induced RPE-specific *Erk2* deletion (RPE-DKO), while controls received PBS. Analyses were at 2 weeks, 1 month, 2 months, 4 months, or 1 year after injection.
- Functional and structural assays: fundus photography, OCT, scotopic and photopic ERG, immunohistochemistry, TUNEL, electron microscopy, flat-mount RPE-choroid analysis, Western blot, qPCR, and HPLC retinoid measurements.
- Cell and molecular assays: HEK293T/HEK293 and ARPE19 cells; luciferase reporter assays with RPE65 or LRAT promoter constructs and an AP-1-deleted RPE65 construct; treatment with U0126 (10 nM) or PD0325901 (2 μM) for 24 h; AP-1 binding ELISA and EMSA.
Limitations
- Stated: The authors cannot exclude that other regulatory elements close to the AP-1 site were also deleted from the RPE65 promoter reporter, which could explain the low promoter activity observed without the AP-1 sequence.
- Stated: They cannot totally exclude that ERK1/2 was also depleted in some IPL vessels because of ectopic Cre expression in IPL vessels (but not choroidal vessels) in certain mice, which may impact INL degeneration; further analyses are required to decipher the mechanisms leading to INL degeneration.
- Evident from the text: Some supporting observations are reported as data not shown (e.g., STRA6 decrease and control retinal degeneration data), and the GNAT1 immunostaining decrease was not confirmed by qPCR or Western blot because the GNAT1/tubulin ratio was unchanged.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG 2 Loss of ERK1/2 in the RPE leads to vision impairment. (A) Representative fundus images of CTL and RPE-DKO mice at 2 or 4 months. (B) Representative OCT images of CTL and RPE-DKO mice at 4 months. (C) Graphs of the scotopic (n = 10) and photopic (n = 4) ERG responses (b wave) of CTL and RPE-DKO mice at 2 months. (*, P < 0.05; **, P < 0.001). The right panel shows the scotopic (50 mcd s/m2) and photopic (10 mcd s/m2) ERG responses of CTL and RPE-DKO mice. (D) Chromatographs and quantification of retinoids (retinol [ROL] and retinal [RAL]) measured in the retina and in the RPE-choroid from mice at 1 month, which were dark adapted for 16 h, or measured in whole eyes (containing the retina, RPE, and choroid) from mice (same conditions) exposed to 1,000 mA of light for 2 h.](https://figures.cochat.ai/paper-figures/58ad19e4e4c449ecb7c265a139c9be9b/loss-of-extracellular-signal-regulated-kinase-1-2-in-the-retinal-pigment-figure-2.jpg)





Verification
Claims the paper makes
19 Valid · 1 Not valid · 16 Not checked · 72 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“previous work from our laboratory showed that A2E induces a strong decrease in extracellular signal-regulated kinase 1/2 (ERK1/2) activity in polarized ARPE19 and isolated mouse RPE cells”
What the sources say
- Supportedcites [9] source
The Results section reports a marked decrease of more than 50% in ERK1/2 activity in polarized ARPE19 cells after prolonged A2E exposure, and a similar decrease in isolated mouse RPE cells. The Discussion confirms the finding in both cell types; the decrease was observed with long-term exposure, not the short-term treatment tested. (LLM, conf=0.92)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We previously showed that the inhibition of the ERK1/2 pathway in ARPE19 cells as well as in isolated mouse RPE cells leads to a reduction of Rpe65 mRNA expression”
What the sources say
- Partly supportedcites [9] sourceExperimental — accuracy not yet measured
The Results (Figure 4B–C; page not provided) report reduced RPE65 mRNA in A2E-treated polarized ARPE19 cells, alongside reduced ERK1/2 activity. In isolated mouse RPE cells, the reported RPE65 reduction is in protein, not mRNA. These results also do not establish that ERK1/2 inhibition itself caused the mRNA reduction. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“the inhibition of ERK1/2 leads to a significant decrease in the level of retinal pigment epithelium-specific protein of 65 kDa (RPE65)”
What the sources say
- Supportedcites [9] source
The Abstract (page unavailable) states that A2E, via decreased ERK1/2 activity, significantly decreases RPE65 expression in ARPE19 cells and isolated mouse RPE. The Results (Figure 4; page unavailable) report decreased ERK1/2 activity alongside decreased RPE65 protein in isolated mouse RPE cells. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Even if Cre expression is observed specifically in RPE cells, as shown for Cre-tdTomato mice ( Fig. 1 ) and as previously described ( 30 ),”
What the sources say
- Partly supportedcites [30] sourceExperimental — accuracy not yet measured
The Results and Discussion describe Cre activity as restricted to RPE cells in the retina, supporting the cited point. They also report weak expression in the optic nerve, so the source does not support an unqualified claim that expression occurs only in RPE cells. The Cre-tdTomato observation is attributed to the citing paper’s own Figure 1, not to this source. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, the inhibition of the ERK1/2 pathway by U0126 also induces a significant decrease in the level of RPE65 expression ( 9 ).”
What the sources say
- Partly supportedcites [9] sourceExperimental — accuracy not yet measured
The Results (Figure 4; page not specified) report that A2E treatment reduced ERK1/2 activity and significantly decreased RPE65 expression. The paper identifies U0126 as an ERK1/2 inhibitor in Materials and Methods, but the passages do not show that U0126 itself decreased RPE65 expression. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
42 more claims · 2 with their cited sources checked
Create a free account to see all 108 claims and every source verdict.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 46
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These effects seem to be dose-dependent, however, and reliant on a non-total ERK1/2 inhibition, since specific ablation of ERK1/2 in mouse RPE cells leads to RPE cell death and retinal degeneration [ 44 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“The second consequence includes changes in the morphology of the RPE and in the RPE cell death process, which appears later, 2 months after Cre induction, when most of the hallmarks of retinal degeneration are visible in the eyes of RPE-DKO mice.”
“The loss of vision as well as the pronounced retinal degeneration in these mice prompted us to examine the state of the RPE ultrastructure in RPE-DKO mice at 1 month by EM imaging. An overview of the RPE-retina cell layers showed massive shrinkage of the RPE cell layer, a disruption of Bruch's membrane (BM), and PR degeneration ( Fig. 6A ).”
Citations
Cites
THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY
Reynolds, E. S. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.1.208 · Cited by 24,938 · cited 1×
“4% Reynolds’ lead citrate (75) in H2O (Sigma-Aldrich) during 10 min, and rinsed several times with H2O.”
MethodRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
Madisen, L., Zwingman, T. A., Sunkin, S. M., Oh, S. W., Zariwala, H. A., Gu, H., Ng, L. L., Palmiter, R. D., Hawrylycz, M. J., Jones, A. R., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2467 · Cited by 6,907 · cited 2×
“Cre-tdTomato mice were created by crossbreeding VMD2-rtTA/TRE-Cre mice with tdTomato mice (31) to set up the Dox injection protocol and visualize Cre expression.”
MethodActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
The Retinal Pigment Epithelium in Visual Function
Strauss, O. (2005) · Physiological Reviews · doi:10.1152/physrev.00021.2004 · Cited by 2,828 · cited 1×
“Accordingly, interactions of PRs with the RPE are essential for PR survival (67).”
BackgroundPathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
Kyriakis, J. M., & Avruch, J. (2012) · Physiological Reviews · doi:10.1152/physrev.00028.2011 · Cited by 1,466
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265 · cited 2×
“This pathology is characterized by the presence of soft and/or hard drusen (extracellular debris and deposits), hyper- and hypopigmentation of retinal pigment epithelium (RPE) cells, RPE and photoreceptor (PR) apoptosis, as well as choroidal neovascularization (CNV) (1).”
BackgroundTargeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
Meloche, S., & Pouysségur, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210414 · Cited by 1,091
Self-citationThe MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation
Plotnikov, A., Zehorai, E., Procaccia, S., & Seger, R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.12.012 · Cited by 986
Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle
Redmond., T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J.-X., Crouch, R. K., & Pfeifer, K. (1998) · Nature Genetics · doi:10.1038/3813 · Cited by 929 · cited 1×
“RPE65 is an enzyme involved in vitamin A metabolism in RPE cells (35).”
BackgroundRauen, K. A. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153523 · Cited by 879
Rinehart, J., Adjei, A. A., LoRusso, P. M., Waterhouse, D., Hecht, J. R., Natale, R. B., Hamid, O., Varterasian, M., Asbury, P., Kaldjian, E. P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.185 · Cited by 645 · cited 1×
“Treatments last approximately 3 weeks and are repeated every month (71, 72).”
BackgroundRPE lipofuscin and its role in retinal pathobiology
Sparrow, J. R., & Boulton, M. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.01.007 · Cited by 644 · cited 1×
“because A2E accumulation is linked to an increase of lipofuscin levels with age (7).”
BackgroundMorimura, H., Fishman, G. A., Grover, S. A., Fulton, A. B., Berson, E. L., & Dryja, T. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3088 · Cited by 481 · cited 1×
“Mutations in RPE65 are associated with several retinal disorders, including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA) (36), and early-onset retinal dystrophy (RD) in children (37).”
BackgroundRetinal age pigments generated by self-assembling lysosomotropic detergents
Eldred, G. E., & Lasky, M. R. (1993) · Nature · doi:10.1038/361724a0 · Cited by 457
Transcriptional regulation by MAP kinases
Davis, R. J. (1995) · Molecular Reproduction and Development · doi:10.1002/mrd.1080420414 · Cited by 429 · cited 3×
“There are two different groups of MAPKs: the conventional (ERK1/2/5, p38 kinases, and Jun N-terminal kinase 1/2/3 [JNK1/2/3]) and the atypical (ERK3/4, ERK7, and Nemo-like kinase [NLK]) MAPKs (13).”
BackgroundInfluentialRedmond, T. M., Poliakov, E., Yu, S., Tsai, J.-Y., Lu, Z., & Gentleman, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504167102 · Cited by 409 · cited 1×
“Much effort has been devoted to deciphering the roles of various genetic mutations that are linked to these diseases (38).”
BackgroundZhou, J., Jang, Y. P., Kim, S. R., & Sparrow, J. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604255103 · Cited by 358
Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin.
Holz, F. G., Schütt, F., Kopitz, J., Eldred, G. E., Kruse, F. E., Völcker, H. E., & Cantz, M. (1999) · PubMed · Cited by 281
ERK and cell death: ERK1/2 in neuronal death
Subramaniam, S., & Unsicker, K. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07367.x · Cited by 263 · cited 1×
“This complexity has been described in many studies (27, 28) and is a”
BackgroundPyakurel, A., Savoia, C., Hess, D., & Scorrano, L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.021 · Cited by 244 · cited 1×
“This complexity has been described in many studies (27, 28) and is a”
BackgroundSelf-citationFrom basic research to clinical development of MEK1/2 inhibitors for cancer therapy
Frémin, C., & Meloche, S. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-8 · Cited by 243
Self-citationHaura, E. B., Ricart, A. D., Larson, T. G., Stella, P. J., Bazhenova, L., Miller, V. A., Cohen, R. B., Eisenberg, P. D., Selaru, P., Wilner, K. D., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1920 · Cited by 237
Lawrence, M. C., Jivan, A., Shao, C., Duan, L., Goad, D., Zaganjor, E., Osborne, J., McGlynn, K., Stippec, S., Earnest, S., et al. (2008) · Cell Research · doi:10.1038/cr.2008.37 · Cited by 229
Early-onset severe rod-cone dystrophy in young children with RPE65 mutations.
Lorenz, B., Gyűrűs, P., Preising, M. N., Bremser, D., Gu, S., Andrassi-Darida, M., Gerth, C., & Gal, A. (2000) · PubMed · Cited by 210
ERK regulates Golgi and centrosome orientation towards the leading edge through GRASP65
Bisel, B., Wang, Y., Wei, J.-H., Xiang, Y., Tang, D., Miron-Mendoza, M., Yoshimura, S.-I., Nakamura, N., & Seemann, J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200805045 · Cited by 184 · cited 1×
“In addition to its role in cell cycle control, ERK1/2 is also implicated in centrosome orientation (58), which is crucial for cytokinesis.”
BackgroundWestenskow, P., Piccolo, S., & Fuhrmann, S. (2009) · Development · doi:10.1242/dev.032136 · Cited by 175 · cited 3×
“Moreover, the activation of ERK1/2 is associated with the activation of the Wnt/ -catenin pathway (45, 46), which plays a key role in the expression of the RPE-specific transcription factors microphthalmia-associated transcription factor (MITF) and OTX2 (47).”
BackgroundOncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer
Lemieux, E., Cagnol, S., Beaudry, K., Carrier, J., & Rivard, N. (2015) · Oncogene · doi:10.1038/onc.2014.416 · Cited by 164 · cited 1×
“Moreover, the activation of ERK1/2 is associated with the activation of the Wnt/ -catenin pathway (45, 46), which plays a key role in the expression of the RPE-specific transcription factors microphthalmia-associated transcription factor (MITF) and OTX2 (47).”
BackgroundThe Biochemistry of the Visual Cycle
Rando, R. R. (2001) · Chemical Reviews · doi:10.1021/cr960141c · Cited by 163
Chen, M., Rajapakse, D., Fraczek, M., Luo, C., Forrester, J. V., & Xu, H. (2016) · Aging Cell · doi:10.1111/acel.12447 · Cited by 159 · cited 1×
“The involvement of cytokinesis defects as well as RPE dysfunctions and RPE cell death in aging eyes was recently described (55).”
BackgroundBharti, K., Gasper, M., Ou, J., Brucato, M., Clore-Gronenborn, K., Pickel, J., & Arnheiter, H. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002757 · Cited by 158 · cited 1×
“In conjunction with protein paired box 6 (PAX6), MITF and OTX2 are key factors in RPE development (48).”
BackgroundMartinez-Garcia, M., Banerji, U., Albanell, J., Bahleda, R., Dolly, S., Kraeber-Bodéré, F., Rojo, F., Routier, E., Guarin, E., Xu, Z.-X., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0742 · Cited by 151 · cited 1×
“by mechanism-based side effects of blurred vision and altered light perception (20, 21).”
BackgroundAblonczy, Z., Higbee, D., Anderson, D. M., Dahrouj, M., Grey, A. C., Gutierrez, D., Koutalos, Y., Schey, K. L., Hanneken, A., & Crouch, R. K. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12250 · Cited by 146 · cited 1×
“and lipofuscin fluorescence in the human RPE (6), it remains unclear whether metab-”
BackgroundZnoiko, S. L., Rohrer, B., Lu, K., Lohr, H. R., Crouch, R. K., & Ma, J.-X. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0653 · Cited by 146
Ocular Toxicity of Targeted Therapies
Renouf, D. J., Velazquez-Martin, J. P., Simpson, R., Siu, L. L., & Bedard, P. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5851 · Cited by 139
Lampert, J. M., Holzschuh, J., Hessel, S., Driever, W., Vogt, K., & von Lintig, J. (2003) · Development · doi:10.1242/dev.00437 · Cited by 138
Self-citation(2001) · PubMed · Cited by 136
STRA6 is critical for cellular Vitamin A uptake and homeostasis
Amengual, J., Zhang, N., Kemerer, M., Maeda, T., Palczewski, K., & Von Lintig, J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu258 · Cited by 134 · cited 1×
“These results phenocopy some of the phenotypes observed for Stra6 / mice, including low retinoid content, the lack of an ERG response, decreases of BM and RPE lengths, and altered morphology of RPE cells (53).”
ResultCone Opsin Mislocalization in Rpe65−/−Mice: A Defect That Can Be Corrected by 11-cis Retinal
Rohrer, B., Lohr, H. R., Humphries, P., Redmond, T. M., Seeliger, M. W., & Crouch, R. K. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0533 · Cited by 133
An EGFR-ERK-SOX9 Signaling Cascade Links Urothelial Development and Regeneration to Cancer
Ling, S., Chang, X., Schultz, L., Lee, T. K., Chaux, A., Marchionni, L., Netto, G. J., Sidransky, D., & Berman, D. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3072 · Cited by 121 · cited 1×
“Interestingly, ERK1/2 and SOX9 signaling pathways were recently shown to interact in urothelial carcinoma (43) and zebrafish sex determination (44).”
BackgroundMitogen-Activated Protein Kinases Promote WNT/β-Catenin Signaling via Phosphorylation of LRP6
Červenka, I., Wolf, J., Mašek, J., Krejci, P., Wilcox, W. R., Kozubík, A., Schulte, G., Gutkind, J. S., & Bryja, V. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00550-10 · Cited by 117 · cited 1×
“Moreover, the activation of ERK1/2 is associated with the activation of the Wnt/ -catenin pathway (45, 46), which plays a key role in the expression of the RPE-specific transcription factors microphthalmia-associated transcription factor (MITF) and OTX2 (47).”
BackgroundMAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE19 cells
Roduit, R., & Schorderet, D. F. (2008) · Apoptosis · doi:10.1007/s10495-008-0179-8 · Cited by 110 · cited 1×
“An AP-1 binding assay (TransAM AP-1 kit; Active Motif) was carried out, as described previously (24), on nuclear extracts from ARPE19 cells.”
MethodSelf-citationERK1/2 activation is a therapeutic target in age-related macular degeneration
Dridi, S., Hirano, Y., Tarallo, V., Kim, Y., Fowler, B. J., Ambati, B. K., Bogdanovich, S., Chiodo, V. A., Hauswirth, W. W., Kugel, J. F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206494109 · Cited by 105 · cited 9×
“An accumulation of intracellular lipofuscin occurs in both forms of ARMD.”
BackgroundMethodInfluentialAmengual, J., Golczak, M., Palczewski, K., & von Lintig, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353979 · Cited by 93 · cited 1×
“Because STRA6 and LRAT work together to retrieve retinoids from the blood circulation (52), such diminution may explain the reduction of the retinoid content observed in RPE-DKO mice.”
BackgroundVoisin, L., Saba-El-Leil, M. K., Julien, C., Frémin, C., & Meloche, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00131-10 · Cited by 92 · cited 7×
“The VMD2-rtTA/ TRE-Cre; Erk1 / ; Erk2Δ/Δ (RPE-DKO) line was then compared to the Erk1 / ; Erk2f/f line as control (CTL) mice.”
BackgroundMethodInfluentialSelf-citation(2002) · PubMed · Cited by 87
MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity
Duncan, K. E., Chang, L. Y., & Patronas, M. (2015) · Eye · doi:10.1038/eye.2015.82 · Cited by 87 · cited 2×
“by mechanism-based side effects of blurred vision and altered light perception (20, 21).”
BackgroundLongbottom, R., Fruttiger, M., Douglas, R. H., Martinez-Barbera, J. P., Greenwood, J., & Moss, S. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902593106 · Cited by 85 · cited 1×
“In this RPECreER/DTA model, functional analysis showed very low scotopic and photopic ERG responses as well as PR degeneration (66).”
MethodInducible Expression of Cre Recombinase in the Retinal Pigmented Epithelium
Le, Y.-Z., Zheng, W., Rao, P.-C., Zheng, L., Anderson, R. E., Esumi, N., Zack, D. J., & Zhu, M. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1105 · Cited by 79 · cited 3×
“1) and as previously described (30), we also noted the ectopic expression of Cre in IPL vessels (but not in choroidal vessels) in certain mice.”
BackgroundMethodSelf-citationMasuda, T., Wahlin, K. J., Wan, J., Hu, J., Maruotti, J., Yang, X., Iacovelli, J., Wolkow, N., Kist, R., Dunaief, J. L., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556738 · Cited by 75 · cited 1×
“They showed that SOX9 acts synergistically with orthodenticle homeobox 2 (OTX2) to activate RPE65 gene expression (42).”
BackgroundInflammation in Dry Age-Related Macular Degeneration
Rodrigues, E. B. (2007) · Ophthalmologica · doi:10.1159/000099293 · Cited by 73 · cited 1×
“The dry form is characterized by the formation of drusen between RPE cells and Bruch’s membrane (2).”
BackgroundSox9-related signaling controls zebrafish juvenile ovary–testis transformation
Sun, D., Zhang, Y., Wang, C., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.456 · Cited by 71 · cited 1×
“Interestingly, ERK1/2 and SOX9 signaling pathways were recently shown to interact in urothelial carcinoma (43) and zebrafish sex determination (44).”
BackgroundRPE65 is essential for the function of cone photoreceptors in NRL-deficient mice
Wenzel, A., von Lintig, J., Oberhauser, V., Tanimoto, N., Grimm, C., & Seeliger, M. W. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0652 · Cited by 66 · cited 1×
“The dependence of cone PR survival on RPE65 was reported previously (62); therefore, the direct regulation of RPE65 by ERK1/2 could account, at least in part, for the severe cone dystrophy found in RPE-DKO mice.”
BackgroundNovel method for the rapid isolation of RPE cells specifically for RNA extraction and analysis
Xin-Zhao Wang, C., Zhang, K., Aredo, B., Lu, H., & Ufret-Vincenty, R. L. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.06.003 · Cited by 60 · cited 1×
“RPE mRNA was extracted by using a previously described protocol (73), while retinas and RPE-choroids were extracted by using the following protocol.”
MethodKokkinopoulos, I., Shahabi, G., Colman, A., & Jeffery, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018921 · Cited by 58 · cited 1×
“Whereas central RPE cells are senescent, peripheral cells proliferate, and ERK1/2 could be important for their maintenance (59, 60).”
BackgroundQin, S., McLaughlin, A. P., & De Vries, G. W. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0318 · Cited by 57 · cited 1×
“The activation of the ERK1/2 pathway was also responsible for the 15-deoxy-Δ12,14-prostaglandin J2 (dPGJ2)-dependent protection of RPE cells from oxidative injury (61).”
BackgroundIriyama, A., Fujiki, R., Inoue, Y., Takahashi, H., Tamaki, Y., Takezawa, S., Takeyama, K., Jang, W.-D., Kato, S., & Yanagi, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708989200 · Cited by 56
Localizations of visual cycle components in retinal pigment epithelium.
(2009) · PubMed Central · Cited by 52
Boulanger, A., Liu, S., Henningsgaard, A. A., Yu, S., & Redmond, T. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003441200 · Cited by 50 · cited 1×
“Several studies analyzed the promoter region of the RPE65 gene (33, 39), but little is known about the factors involved in its transcriptional regulation.”
BackgroundAn easy, rapid method to isolate RPE cell protein from the mouse eye
Wei, H., Xun, Z., Granado, H., Wu, A., & Handa, J. T. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.09.015 · Cited by 47 · cited 1×
“RPE cell lysates were prepared as previously described (74).”
MethodSTARNES, A. C., HUISINGH, C., MCGWIN, G., SLOAN, K. R., ABLONCZY, Z., SMITH, R. T., CURCIO, C. A., & ACH, T. (2016) · Visual Neuroscience · doi:10.1017/s0952523815000310 · Cited by 46 · cited 1×
“RPE multinucleation, which has been reported for humans (54), could result from a cytokinesis defect.”
BackgroundSchoenberger, S. D., & Kim, S. J. (2013) · Case Reports in Ophthalmological Medicine · doi:10.1155/2013/673796 · Cited by 46
Niro, A., Strippoli, S., Alessio, G., Sborgia, L., Recchimurzo, N., & Guida, M. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.07.035 · Cited by 45
(1998) · PubMed · Cited by 42
Li, S., Lee, J., Zhou, Y., Gordon, W. C., Hill, J. M., Bazan, N. G., Miner, J. H., & Jin, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2428-12.2013 · Cited by 36 · cited 1×
“Retinoic acid has been suggested to participate in the downregulation of RPE65 (40) and of fatty acid transporter protein 4 (FATP4) and elongation of very-long-chain fatty acid protein 1 (ELOVL1) (41).”
BackgroundYoshikawa, T., Mizuno, A., Yasumuro, H., Inami, W., Vergara, M. N., Del Rio‐Tsonis, K., & Chiba, C. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00935.x · Cited by 31 · cited 1×
“Moreover, ERK1/2 signaling is necessary to allow the entry of RPE cells into cell cycling and RPE cell proliferation (57).”
BackgroundEffective and Sustained Delivery of Hydrophobic Retinoids to Photoreceptors
Tang, P. H., Fan, J., Goletz, P. W., Wheless, L., & Crouch, R. K. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5766 · Cited by 29
Hecquet, C., Lefevre, G., Valtink, M., Engelmann, K., & Mascarelli, F. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0519 · Cited by 29
Zolfaghari, R., & Ross, A. C. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.08.001 · Cited by 21 · cited 12×
“At the onset of retinal degeneration, the loss of ERK1/2 led to a specific decrease in the level of RPE65 with the mislocalization of lecithin retinol acyltransferase (LRAT).”
MethodInfluentialDonovan, M., Doonan, F., & Cotter, T. G. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07056.x · Cited by 18 · cited 1×
“play a survival role during development (22).”
Down-regulation of RPE65 protein expression and promoter activity by retinoic acid.
Chen, Y., Ma, J.-X., & Crouch, R. K. (2003) · PubMed · Cited by 13
Balmer, D., Bapst-Wicht, L., Pyakurel, A., Emery, M., Nanchen, N., Bochet, C. G., & Roduit, R. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00043 · Cited by 6 · cited 2×
“In addition, the inhibition of the ERK1/2 pathway by U0126 also induces a significant decrease in the level of RPE65 expression (9).”
BackgroundSelf-citationERK1/2 pathway is activated in degenerated Rpe65-deficient mice
Métrailler, S., Emery, M., Schorderet, D. F., Cottet, S., & Roduit, R. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.08.015 · Cited by 5 · cited 4×
“Quantitative PCR was carried out as described previously (23), using 100 nM primers.”
BackgroundMethodInfluentialSelf-citation
Cited by
Yang, Y.-C., Chien, Y., Yarmishyn, A. A., Lim, L.-Y., Tsai, H.-Y., Kuo, W., Tsai, P., Yang, S.-H., Hong, S.-I., Chen, S., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.06.004 · Cited by 73
“ERK was completely depleted by conditional knockout of Erk1 and Erk2 genes in the mouse RPE, which led to diminished RPE65 expression and induced retinal degeneration [69].”
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“These effects seem to be dose-dependent, however, and reliant on a non-total ERK1/2 inhibition, since specific ablation of ERK1/2 in mouse RPE cells leads to RPE cell death and retinal degeneration [44].”
BackgroundGlabridin Attenuates the Retinal Degeneration Induced by Sodium Iodate In Vitro and In Vivo
Aung, K. H., Liu, H., Ke, Z., Jiang, S., & Huang, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.566699 · Cited by 20
“The ERK1/2 pathway is assumed to be a direct regulator of the visual cycle and a critical component of the viability of RPE and photoreceptor cells (Pyakurel et al., 2017).”
BackgroundHuang, Y., Chen, B.-C., Chang, K., Hsieh, M., Sheu, G., Hsiao, C., & Tsai, N. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121815 · Cited by 18
Hsu, D., Kwon, J. H., Ng, R., Makita, S., Yasuno, Y., Šarunic, M. V., & Ju, M. J. (2020) · Biomedical Optics Express · doi:10.1364/boe.403209 · Cited by 18
Metadata
- Authors
- Pyakurel, A., Balmer, D., Saba-El-Leil, M. K., Kizilyaprak, C., Daraspe, J., Humbel, B. M., Voisin, L., Le, Y. Z., von Lintig, J., Meloche, S., & Roduit, R.
- Affiliations
- Institut de Recherche en Opthalmologie (CH)
- Institute for Research in Immunology and Cancer (CA)
- University of Lausanne (CH)
- University of Oklahoma Health Sciences Center (US)
- Department of Pharmacology, School of Medicine, Case Western Reserve University
- Corresponding author
- Roduit, Raphaël
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2017-12-01
- Volume
- 37
- Issue
- 24
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC5705814
- OpenAlex
- W2767028946
- Cited by
- 20
- References
- 76
- Citations by year
- 2025: 2 · 2024: 8 · 2023: 5 · 2021: 1 · 2020: 4
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular and Cellular Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, cc-by)
- IRIS (submittedVersion, cc-by)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Funders
- Gelbert Foundation
- Art & Vie Foundation
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Keywords
- ERK signaling, retinal pigment epithelium, RPE65, retinal degeneration, age-related macular degeneration, visual cycle, conditional gene disruption, kinase inhibitors, ocular adverse effects
- MeSH terms
- Retinoid Isomerohydrolase, Animals, Macular Degeneration, Retina, Retinoids, Mice, Knockout, cis-trans-Isomerases, Mitogen-Activated Protein Kinase 1, MAP Kinase Signaling System, Models, Animal, Mice, Retinal Pigment Epithelium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.